Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-03-08
2005-03-08
Morris, Patricia L. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S271400
Reexamination Certificate
active
06864268
ABSTRACT:
The present invention provides β3-adrenergic receptor agonists of structural Formula (I) as well as pharmaceutical formulations thereof and methods for treating β3-adrenergic receptor-mediated diseases, conditions, or disorders using such compounds.
REFERENCES:
patent: 4358455 (1982-11-01), Atkinson et al.
patent: 4478849 (1984-10-01), Ainsworth et al.
patent: 4918091 (1990-04-01), Cantello et al.
patent: 5019578 (1991-05-01), Fisher et al.
patent: 5030640 (1991-07-01), Fisher et al.
patent: 5051423 (1991-09-01), Lis et al.
patent: 5135932 (1992-08-01), Hauel et al.
patent: 5153210 (1992-10-01), Ainsworth et al.
patent: 5393779 (1995-02-01), Holloway et al.
patent: 5541197 (1996-07-01), Fisher et al.
patent: 5684022 (1997-11-01), Shuto et al.
patent: 5767133 (1998-06-01), Dow et al.
patent: 5776983 (1998-07-01), Washburn et al.
patent: 5840738 (1998-11-01), Bell et al.
patent: 5843972 (1998-12-01), Dow et al.
patent: 5859044 (1999-01-01), Dow et al.
patent: 5977124 (1999-11-01), Dow
patent: 6001856 (1999-12-01), Dow
patent: 6008361 (1999-12-01), Wright
patent: 6090942 (2000-07-01), DeVries et al.
patent: 6187809 (2001-02-01), Miyoshi et al.
patent: 6251925 (2001-06-01), Donaldson et al.
patent: 6265581 (2001-07-01), Bell et al.
patent: 6291489 (2001-09-01), DeVries et al.
patent: 6291491 (2001-09-01), Weber et al.
patent: 6441181 (2002-08-01), Scott
patent: 6451587 (2002-09-01), Burns et al.
patent: 6465501 (2002-10-01), Malamas et al.
patent: 6566377 (2003-05-01), Day et al.
patent: 0236624 (1993-08-01), None
patent: 0543662 (1996-09-01), None
patent: 0764632 (1997-03-01), None
patent: 0882707 (1998-12-01), None
patent: 1236723 (2002-09-01), None
patent: WO 9000548 (1990-01-01), None
patent: WO 9804526 (1998-02-01), None
patent: WO 9821184 (1998-05-01), None
patent: WO 9942455 (1999-08-01), None
patent: WO 9945006 (1999-09-01), None
patent: WO 0040560 (2000-07-01), None
patent: WO 0232897 (2002-04-01), None
patent: WO 0248134 (2002-06-01), None
Lafontaine Jennifer A.
Morgan Bradley P.
Benson Gregg C.
Morris Patricia L.
Musser Arlene K.
Pfizer Inc.
Richardson Peter C.
LandOfFree
β3 adrenergic receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with β3 adrenergic receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and β3 adrenergic receptor agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3413197